跳至主要内容
临床试验/NCT02871375
NCT02871375已完成不适用

DAILIES TOTAL1® Multifocal Clinical Assessment in Challenging Patients

Alcon, a Novartis Company0 个研究点目标入组 170 人开始时间: 2016年8月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
170
主要终点
Binocular High Contrast/High Illumination (HC/HI) Visual Acuity (VA) at Intermediate Distance (80 cm)

研究概览

简要总结

The purpose of this study is to evaluate DAILIES TOTAL1® Multifocal (DTl MF) contact lenses in current multifocal contact lens wearers with symptoms of end of day discomfort compared to their habitual multifocal contact lens correction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must sign an informed consent document;
  • Current daily wearer of soft multifocal contact lenses for at least 6 months with symptoms of contact lens discomfort as defined by the prescreening Eligibility Questionnaire;
  • Requires a near spectacle add of +0.50 to +2.50 diopters (D) (inclusive);
  • Requires lenses within the power range of study lenses to be fitted;
  • Best corrected VA (BCVA) of 20/30 (0.2 logarithmic minimum angle of resolution [logMAR]) or better in each eye at distance;
  • Willing to wear study lenses for a minimum of 5 days per week, 6 hours per day, and attend all study visits;
  • Other protocol-defined inclusion criteria may apply.

排除标准

  • Any eye condition that contraindicates wearing contact lenses as determined by the Investigator;
  • Any use of medications for which contact lens wear could be contraindicated, as determined by the Investigator;
  • Monocular (only one eye functional) or fit with only 1 lens;
  • Fitted with monovision;
  • Prior refractive surgery (e.g., laser vision correction, photorefractive keratectomy, etc.);
  • History of herpetic keratitis, ocular surgery, or irregular cornea;
  • Currently wearing DT1 MF contact lenses;
  • Other protocol-defined exclusion criteria may apply.

研究组 & 干预措施

DT1 MF, then Habitual

Other

Delefilcon A multifocal contact lenses in Period 1, followed by subject's habitual multifocal contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 14 ± 3 days.

干预措施: Delefilcon A multifocal contact lenses (Device)

DT1 MF, then Habitual

Other

Delefilcon A multifocal contact lenses in Period 1, followed by subject's habitual multifocal contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 14 ± 3 days.

干预措施: Habitual multifocal contact lenses (Device)

Habitual, then DT1 MF

Other

Subject's habitual multifocal contact lenses in Period 1, followed by delefilcon A multifocal contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 14 ± 3 days.

干预措施: Delefilcon A multifocal contact lenses (Device)

Habitual, then DT1 MF

Other

Subject's habitual multifocal contact lenses in Period 1, followed by delefilcon A multifocal contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 14 ± 3 days.

干预措施: Habitual multifocal contact lenses (Device)

结局指标

主要结局

Binocular High Contrast/High Illumination (HC/HI) Visual Acuity (VA) at Intermediate Distance (80 cm)

时间窗: Day 14, each product

Visual Acuity (clarity or sharpness of vision) was measured at high contrast level. HC/HI VA was assessed binocularly (both eyes together) at 80 centimeters using an Early Treatment Diabetic Retinopathy Study (ETDRS) chart and measured in logarithm of the minimum angle of resolution (logMAR). A lower logMAR value indicates better visual acuity.

次要结局

  • Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) Score(Day 14, each product)

研究者

发起方
Alcon, a Novartis Company
申办方类型
Industry
责任方
Sponsor

相似试验